Donation

Donate
Myeloma Minute

Los Angeles 2015 Patient & Family Seminar
August 21-22, 2015

Black Swan Research Initiative® Perspectives
Dr. Brian Durie

The most current update, as of August 25, of the Black Swan Research Initiative®. 

View Slides

MagnetisMM3
MagnetisMM-3: Long-Term Efficacy & Safety of Less Frequent Elranatamab Dosing in Relapsed Refractory Multiple Myeloma
Read more
Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone for Newly-Diagnosed Multiple Myeloma
Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone for Newly-Diagnosed Multiple Myeloma: GMMG-HD7 Interim Analysis
Read more
Previous Post
LA PNF: Myeloma101 - Dr. Brian Durie
Next Post
What is the latest news about the Black Swan Research Initiative?

Give Where Most Needed

Learn More